Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
mBio. 2021 Dec 21;12(6):e0281721. doi: 10.1128/mBio.02817-21. Epub 2021 Nov 30.
HIV-1 replicates in cells that express a wide array of innate immune sensors and may do so simultaneously with other pathogens. How a coexisting innate immune stimulus influences the outcome of HIV-1 sensing, however, remains poorly understood. Here, we demonstrate that the activation of a second signaling pathway enables a cyclic GMP-AMP synthase (cGAS)-dependent type I interferon (IFN-I) response to HIV-1 infection. We used RNA sequencing to determine that HIV-1 alone induced few or no signs of an IFN-I response in THP-1 cells. In contrast, when supplemented with suboptimal levels of bacterial lipopolysaccharide (LPS), HIV-1 infection triggered the production of elevated levels of IFN-I and significant upregulation of interferon-stimulated genes. LPS-mediated enhancement of IFN-I production upon HIV-1 infection, which was observed in primary macrophages, was lost by blocking reverse transcription and with a hyperstable capsid, pointing to viral DNA being an essential immunostimulatory molecule. LPS also synergistically enhanced IFN-I production by cyclic GMP-AMP (cGAMP), a second messenger of cGAS. These observations suggest that the DNA sensor cGAS is responsible for a type I IFN response to HIV-1 in concert with LPS receptor Toll-like receptor 4 (TLR4). Small amounts of a TLR2 agonist also cooperate with HIV-1 to induce type I IFN production. These results demonstrate how subtle immunomodulatory activity renders HIV-1 capable of eliciting an IFN-I response through positive cross talk between cGAS and TLR sensing pathways. Innate immune activation is a hallmark of HIV-1 pathogenesis. Thus, it is critical to understand how HIV-1 infection elicits innate immune responses. In this work, we show that HIV-1 infection of macrophages leads to a robust type I interferon (IFN) production only when a second signaling event is initiated by a coexisting immunostimulatory molecule. Our results show that HIV-1 infection alone is not sufficient for triggering a strong IFN response. We find that bacterial membrane components, which are recognized by endosomal innate sensors, enable production of elevated levels of IFNs and significant upregulation of interferon-stimulated genes upon HIV-1 infection. This IFN response is dependent on viral DNA synthesis and prevented by a stable capsid, pointing to an essential role for a DNA sensing molecule. These observations provide new insights into how different innate immune recognition pathways synergize during HIV-1 infection and determine the outcome of innate responses.
HIV-1 在表达广泛的先天免疫传感器的细胞中复制,并且可能与其他病原体同时进行。然而,共存的先天免疫刺激物如何影响 HIV-1 感应的结果,仍然知之甚少。在这里,我们证明了第二种信号通路的激活使环鸟苷酸-腺苷酸合酶 (cGAS)-依赖性 I 型干扰素 (IFN-I) 反应能够对 HIV-1 感染作出反应。我们使用 RNA 测序确定,在 THP-1 细胞中,HIV-1 单独诱导的 IFN-I 反应很少或没有迹象。相比之下,当用亚最佳水平的细菌脂多糖 (LPS) 补充时,HIV-1 感染会引发 IFN-I 的产生水平升高,并显著上调干扰素刺激基因。在原发性巨噬细胞中观察到的 HIV-1 感染时,LPS 介导的 IFN-I 产生增强作用在阻断逆转录和具有超稳定衣壳时丧失,表明病毒 DNA 是一种必需的免疫刺激性分子。LPS 还协同增强了环鸟苷酸-腺苷酸 (cGAMP) 的 IFN-I 产生,cGAMP 是 cGAS 的第二信使。这些观察结果表明,DNA 传感器 cGAS 负责与 LPS 受体 Toll 样受体 4 (TLR4) 一起对 HIV-1 作出 I 型 IFN 反应。少量 TLR2 激动剂也与 HIV-1 合作诱导 I 型 IFN 产生。这些结果表明,如何微妙的免疫调节活性使 HIV-1 能够通过 cGAS 和 TLR 感应途径之间的正对话引发 IFN-I 反应。先天免疫激活是 HIV-1 发病机制的标志。因此,了解 HIV-1 感染如何引发先天免疫反应至关重要。在这项工作中,我们表明,只有当共存的免疫刺激性分子引发第二种信号事件时,巨噬细胞中的 HIV-1 感染才会导致强烈的 I 型干扰素 (IFN) 产生。我们的结果表明,HIV-1 感染本身不足以触发强烈的 IFN 反应。我们发现,细菌膜成分被内体先天传感器识别,使 HIV-1 感染后能够产生更高水平的 IFNs 和显著上调干扰素刺激基因。这种 IFN 反应依赖于病毒 DNA 合成,并被稳定的衣壳阻止,这表明 DNA 感应分子起着至关重要的作用。这些观察结果为不同的先天免疫识别途径如何在 HIV-1 感染期间协同作用并决定先天反应的结果提供了新的见解。